Filter
422
Filtered Results: 422
Text search:
seroprevalence
survey
Featured
Recommendations
27
New Publications
133
Language
Document type
No document type
252
Guidelines
60
Studies & Reports
57
Strategic & Response Plan
16
Manuals
15
Fact sheets
14
Situation Updates
5
Resource Platforms
2
Training Material
1
Countries / Regions
Nigeria
23
Global
16
Sierra Leone
13
Congo, Democratic Republic of
13
India
11
Benin
9
Senegal
9
Latin America and the Carribbean
9
South Africa
9
Tanzania
8
Lesotho
7
Cameroon
7
Africa
7
Western and Central Europe
7
Central African Republic
7
Cambodia
6
Asia
6
Middle East and North Africa
6
Brazil
6
Nepal
5
Rwanda
5
Burkina Faso
5
Uganda
5
Eastern Europe
5
Ukraine
4
Syria
4
West and Central Africa
4
Russia
4
Yemen
4
Zambia
4
Liberia
4
Myanmar / Burma
4
Pakistan
4
Zimbabwe
3
Haiti
3
South–East Asia Region
3
East and Southern Africa
3
Namibia
3
Ethiopia
3
Indonesia
3
Madagascar
3
Colombia
2
Kenya
2
Turkey
2
Ghana
2
Afghanistan
2
Malawi
2
Philippines
2
Guinea
2
Mozambique
2
Germany
2
Bangladesh
2
Vietnam
2
Moldova
2
Somalia
2
Guatemala
2
North Macedonia
1
Chile
1
Iran
1
Albania
1
Niger
1
Peru
1
Qatar
1
Armenia
1
USA
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
North America
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Southern Africa
1
Bolivia
1
Argentina
1
Lebanon
1
Djibouti
1
Egypt
1
Sudan
1
Palestine
1
Honduras
1
Libya
1
Botswana
1
South Sudan
1
Iraq
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
189
Clinical Guidelines
23
Public Health
12
Key Resources
6
Pharmacy & Technologies
5
Capacity Building
1
Women & Child Health
1
Toolboxes
HIV
60
COVID-19
57
NTDs
35
TB
33
Rapid Response
22
Ebola & Marburg
12
Zika
11
Mental Health
7
Planetary Health
6
Polio
5
Refugee
4
Disability
3
Natural Hazards
1
Cholera
1
Caregiver
1
Conflict
1
THELANCETID-D-16-00800 S1473-3099(16)30318-8
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV).
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
Up-to-date Literature review current through: Jan 2015. | This topic last updated: Jan 29, 2015.
International Journal of Infectious Diseases 32 (2015) 170–178
http://dx.doi.org/10.1016/j.ijid.2014.11.023
1201-9712/ß 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http:...
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by...
The Open Infectious Diseases Journal, 2010, 4, 33-37
The present DHR-ICMR guidelines comprehensively address the various concerns regarding the clinical assessment, treatment, and laboratory diagnosis of rickettsial diseases in India and the world. It is hoped that physicians, health care workers, the scientific community, the regulatory agencies, pub...
Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also vectors of chikungunya, yellow fever and Zik...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
5th edition.
